These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 28613262

  • 1. Antimicrobial Activity of Truncated and Polyvalent Peptides Derived from the FKCRRQWQWRMKKGLA Sequence against Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 25923.
    Huertas NJ, Monroy ZJR, Medina RF, Castañeda JEG.
    Molecules; 2017 Jun 14; 22(6):. PubMed ID: 28613262
    [Abstract] [Full Text] [Related]

  • 2. Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Antimicrobial Activity against E. coli ATCC 11775, S. maltophilia ATCC 13636 and S. enteritidis ATCC 13076.
    Huertas Méndez NJ, Vargas Casanova Y, Gómez Chimbi AK, Hernández E, Leal Castro AL, Melo Diaz JM, Rivera Monroy ZJ, García Castañeda JE.
    Molecules; 2017 Mar 12; 22(3):. PubMed ID: 28287494
    [Abstract] [Full Text] [Related]

  • 3. Expression of recombinant Arabian camel lactoferricin-related peptide in Pichia pastoris and its antimicrobial identification.
    Chahardooli M, Niazi A, Aram F, Sohrabi SM.
    J Sci Food Agric; 2016 Jan 30; 96(2):569-75. PubMed ID: 25655077
    [Abstract] [Full Text] [Related]

  • 4. Synergistic bactericide and antibiotic effects of dimeric, tetrameric, or palindromic peptides containing the RWQWR motif against Gram-positive and Gram-negative strains.
    Vargas-Casanova Y, Rodríguez-Mayor AV, Cardenas KJ, Leal-Castro AL, Muñoz-Molina LC, Fierro-Medina R, Rivera-Monroy ZJ, García-Castañeda JE.
    RSC Adv; 2019 Mar 01; 9(13):7239-7245. PubMed ID: 35519960
    [Abstract] [Full Text] [Related]

  • 5. Antibacterial activity of synthetic peptides derived from lactoferricin against Escherichia coli ATCC 25922 and Enterococcus faecalis ATCC 29212.
    León-Calvijo MA, Leal-Castro AL, Almanzar-Reina GA, Rosas-Pérez JE, García-Castañeda JE, Rivera-Monroy ZJ.
    Biomed Res Int; 2015 Mar 01; 2015():453826. PubMed ID: 25815317
    [Abstract] [Full Text] [Related]

  • 6. Effect of Polyvalence on the Antibacterial Activity of a Synthetic Peptide Derived from Bovine Lactoferricin against Healthcare-Associated Infectious Pathogens.
    Vega Chaparro SC, Valencia Salguero JT, Martínez Baquero DA, Rosas Pérez JE.
    Biomed Res Int; 2018 Mar 01; 2018():5252891. PubMed ID: 29984236
    [Abstract] [Full Text] [Related]

  • 7. Bactericidal kinetics of 3 lactoferricins against Staphylococcus aureus and Escherichia coli.
    Ulvatne H, Vorland LH.
    Scand J Infect Dis; 2001 Mar 01; 33(7):507-11. PubMed ID: 11515760
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin.
    Vorland LH, Ulvatne H, Andersen J, Haukland H, Rekdal O, Svendsen JS, Gutteberg TJ.
    Scand J Infect Dis; 1998 Mar 01; 30(5):513-7. PubMed ID: 10066056
    [Abstract] [Full Text] [Related]

  • 13. Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli.
    Flores-Villaseñor H, Canizalez-Román A, Reyes-Lopez M, Nazmi K, de la Garza M, Zazueta-Beltrán J, León-Sicairos N, Bolscher JG.
    Biometals; 2010 Jun 01; 23(3):569-78. PubMed ID: 20195887
    [Abstract] [Full Text] [Related]

  • 14. Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines.
    Vargas Casanova Y, Rodríguez Guerra JA, Umaña Pérez YA, Leal Castro AL, Almanzar Reina G, García Castañeda JE, Rivera Monroy ZJ.
    Molecules; 2017 Sep 29; 22(10):. PubMed ID: 28961215
    [Abstract] [Full Text] [Related]

  • 15. The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells.
    Yang N, Strøm MB, Mekonnen SM, Svendsen JS, Rekdal O.
    J Pept Sci; 2004 Jan 29; 10(1):37-46. PubMed ID: 14959890
    [Abstract] [Full Text] [Related]

  • 16. Secondary Structural Transformation of Bovine Lactoferricin Affects Its Antibacterial Activity.
    Pei J, Xiong L, Bao P, Chu M, Yan P, Guo X.
    Probiotics Antimicrob Proteins; 2021 Jun 29; 13(3):873-884. PubMed ID: 33188636
    [Abstract] [Full Text] [Related]

  • 17. Modification of lysozyme with oleoyl chloride for broadening the antimicrobial specificity.
    Evran S, Yasa I, Telefoncu A.
    Prep Biochem Biotechnol; 2010 Jun 29; 40(4):316-25. PubMed ID: 21108135
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.